ClinicalTrials.gov record
Terminated Phase 1 Interventional

RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer

ClinicalTrials.gov ID: NCT01192763

Public ClinicalTrials.gov record NCT01192763. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer

Study identification

NCT ID
NCT01192763
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
30 participants

Conditions and interventions

Interventions

  • gamma-secretase/Notch signalling pathway inhibitor RO4929097 Drug
  • laboratory biomarker analysis Other
  • neoadjuvant therapy Procedure
  • pharmacological study Other
  • therapeutic conventional surgery Procedure

Drug · Other · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2010
Primary completion
Dec 31, 2011
Completion
Not listed
Last update posted
Sep 29, 2013

Started 2010

United States locations

U.S. sites
6
U.S. states
3
U.S. cities
6
Facility City State ZIP Site status
Tower Cancer Research Foundation Beverly Hills California 90211-1850
City of Hope Medical Center Duarte California 91010
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637-1470
Illinois CancerCare-Peoria Peoria Illinois 61615
Central Illinois Hematology Oncology Center Springfield Illinois 60702
Fort Wayne Medical Oncology and Hematology Inc - State Boulevard Fort Wayne Indiana 46845

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01192763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 29, 2013 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01192763 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →